Actionable insights straight to your inbox

Equities logo

Shire Plc Files SEC Form 425, Prospectuses And Communications, Business Combinations (Jun. 30, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Shire Plc (Form 425) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 3 documents filed with this form. The SEC file number is 0001104659-14-049345.
The contact information for this company is HAMPSHIRE INTL BUSINESS PARK, CHINEHAM BASINGSTOKE, HAMPSHIRE ENGLAND RG X0 R924 8EP, 441256894000.
Our editors provided additional information about Form 425: Filing of certain prospectuses and communications in connection with business combination transactions.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1551152/0001104659-14-049345-index.html.
Keywords for this news article include: Pharmaceutical Preparations, Shire Plc, SEC Filing, Biopharmaceutical Company.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.